Quinfamide
Clinical data
Routes of
administration		Oral
ATC code
  • None
Identifiers
  • [1-(2,2-dichloroacetyl)-3,4-dihydro-2H-quinolin-6-yl] furan-2-carboxylate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.057.690
Chemical and physical data
FormulaC16H13Cl2NO4
Molar mass354.18 g·mol−1
3D model (JSmol)
  • C1CC2=C(C=CC(=C2)OC(=O)C3=CC=CO3)N(C1)C(=O)C(Cl)Cl
  • InChI=1S/C16H13Cl2NO4/c17-14(18)15(20)19-7-1-3-10-9-11(5-6-12(10)19)23-16(21)13-4-2-8-22-13/h2,4-6,8-9,14H,1,3,7H2 ☒N
  • Key:SBJGFIXQRZOVTO-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Quinfamide is a drug that has anti-parasitic properties.[1]

Synthesis

Quinfamide is one of a relatively small family of antiamoebic compounds containing a dichloroacetamide function.

Quinfamide synthesis:[2][3]

The synthesis begins by amidation of 6-hydroxytetrahydroquinoline with dichloroacetyl chloride. The sequence is completed by acylation with 2-furoyl chloride.

References

  1. ↑ Davila-Gutierrez CE, Vasquez C, Trujillo-Hernandez B, Huerta M (March 2002). "Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children". The American Journal of Tropical Medicine and Hygiene. 66 (3): 251–4. doi:10.4269/ajtmh.2002.66.251. PMID 12139216.
  2. ↑ US 3997542, Bailey, Denis Mahlon, "1-(Halogenated-acetyl)-1,2,3,4-tetrahydro-6-quinolinols and esters thereof", published 1976-12-14, assigned to Sterling Drug Inc.
  3. ↑ Bailey DM, Mount EM, Siggins J, Carlson JA, Yarinsky A, Slighter RG (May 1979). "1-(Dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinol esters. New potent antiamebic agents". Journal of Medicinal Chemistry. 22 (5): 599–601. doi:10.1021/jm00191a031. PMID 458814.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.